ZIM Laboratories Limited (ZIMLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.96B |
| Enterprise Value | 3.97B |
| P/E Ratio | 104.75 |
| PEG Ratio | -2.01 |
| Price/Sales Ratio | 1.78 |
| Price/Book Ratio | 2.07 |
| Enterprise/Revenue | 2.05 |
| Enterprise/EBITDA | 22.93 |
Fiscal Year
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.02 |
| Operating Margin | 0.03 |
AD
Management Effectiveness
| Return On Assets | 0.01 |
| Return On Equity | 0.02 |
Income Statement
| Revenue | 3.69B |
| Revenue/Share | 76.09 |
| Gross Profit | 616.36M |
| EBITDA | 300.1M |
| Net Income | 58.38M |
| Diluted EPS | 1.19 |
Balance Sheet
| Total Cash | 278.02M |
| Total Cash/Share | 5.65 |
| Total Debt | 1.26B |
| Total Debt/Equity | 0.43 |
| Current Ratio | 1.45 |
| Book Value Per Share | 60.18 |
Price History
| 52-Week Change | 10.9 |
| 52-Week High | 129.3 |
| 52-Week Low | 59.31 |
| Moving Average 50 Days | 98.42 |
| Moving Average 200 Days | 77.96 |
Statistics
| Average Volume | 100,575 |
| Shares Outstanding | 53.55M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
| Last Split Date | December 22, 2022 |
AD
